In 1984, Congress ensured access to cost-saving generic medications through protections and incentives within the watershed Hatch-Waxman framework. It was a win for patients who gained access to more affordable medicines, transforming the health of millions through low-cost generic medications. In the last decade, this important legislation saved our healthcare system over $2.4 trillion. In 2021 alone, generic and biosimilar drugs drove $373 billion in savings to the system.
Read Full Article »
